Itamar Pursuing Sleep Apnea As First Application Of PAT Platform
This article was originally published in The Gray Sheet
Executive Summary
Respironics will distribute Itamar Medical's peripheral arterial tonometry technology (PAT) with its sleep monitoring instruments to assist in the diagnosis of sleep apnea.
You may also be interested in...
Physician Office Labs At Cholestech’s Fingertips: CRP, Waived Tests In Reach
Cholestech will conduct clinical studies to support Medicare reimbursement for Endo-Pat 2000, a device that measures vascular endothelial dysfunction, an early-stage marker of atherosclerosis
Physician Office Labs At Cholestech’s Fingertips: CRP, Waived Tests In Reach
Cholestech will conduct clinical studies to support Medicare reimbursement for Endo-Pat 2000, a device that measures vascular endothelial dysfunction, an early-stage marker of atherosclerosis
Respironics Awakens In April; Strong Sales Spark 13% Stock Price Gain
Respironics' third-quarter results awakened Wall Street to the fact that the sleep-disorder equipment manufacturer had shrugged off its recent reimbursement difficulties. The company's stock price was up 13%, or 1-7/8, in April, closing the month at 16-1/4.